Biotech ASLAN Pharmaceuticals Announces First Patient Screened in Study of Eblasakimab in Dupilumab Experienced Atopic Dermatitis Patients December 15, 2022
Biotech CLASS ACTION UPDATE for EIGR, VERU and TWST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 14, 2022
Biotech Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Announces Receipt of Extension to Meet the Nasdaq’s Minimum Bid Price Requirement December 14, 2022
Biotech ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 14, 2022
Biotech DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2023 in Eiger Lawsuit – EIGR December 14, 2022
Biotech Urica Therapeutics Expands Exclusive License Agreement with Fuji Yakuhin Co. Ltd. to Develop Dotinurad in Additional Territories Including Turkey and the Middle East and North Africa December 14, 2022
Biotech Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial December 14, 2022
Biotech Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer December 14, 2022
Search
